期刊文献+

血脑屏障上的P-糖蛋白和乳腺癌耐药蛋白及其研究方法 被引量:5

P-glycoprotein and breast cancer resistance protein at the blood-brain barrier and their research methods
原文传递
导出
摘要 血脑屏障上存在的药物转运体P-糖蛋白和乳腺癌耐药蛋白可以将包括药物在内的小分子等排出大脑,发挥保护作用,但是也给脑部疾病的治疗带来困扰,药物很难在脑内达到有效的浓度,从而无法发挥应有的药效,是导致治疗失败的主要原因。本文主要对血脑屏障上的P-糖蛋白和乳腺癌耐药蛋白的功能特点、研究方法和蛋白定量分析进行了综述。 P-glycoprotein ( P-gp ) and breast cancer resistance protein ( BCRP ), drug transporters at the blood- brain barrier ( BBB ), can protect the brain from exogenous small molecules, such as drugs. However, it is also a major challenge for the treatment of central nervous system diseases since drugs cannot cross the BBB essentially to reach an effective concentration. In this paper, the functional characteristics, research methods and quantitative analysis of P-glycoprotein and breast cancer resistance protein at the blood brain barrier were reviewed.
出处 《药物分析杂志》 CAS CSCD 北大核心 2017年第9期1557-1565,共9页 Chinese Journal of Pharmaceutical Analysis
基金 国家自然科学基金(No.81173020 NO.81373376)
关键词 血脑屏障 P-糖蛋白 乳腺癌耐药蛋白 细胞模型 基因敲除动物模型 蛋白质定量 blood-brain barrier P-glycoprotein breast cancer resistance protein cell mode/ gene knockout animal model protein quantification
  • 相关文献

参考文献8

二级参考文献230

  • 1赵亚超,张志培,韩勇,朱长亮,朱以芳,钟代星,程庆书.非小细胞肺癌组织BCRP和GST-π表达及其与化疗敏感性关系的研究[J].中华肿瘤防治杂志,2008,15(12):897-900. 被引量:4
  • 2梁延春,王秀丽.O^6-苄基鸟嘌呤对耐药细胞系K562/DOX多药耐药逆转作用的研究[J].白血病.淋巴瘤,2001,10(3):140-141. 被引量:1
  • 3兰轲,蒋学华.P-糖蛋白及其抑制剂研究进展[J].中国药房,2005,16(10):787-790. 被引量:7
  • 4Chen YN, Mickley LA, Schwartz AM, et al. Characterization of adriamycin- resistant human breast cancer cells which display overexpression of a novel resistance- related membrane protein[J]. J Biol Chem, 1990, 265:10073-10080.
  • 5ICJ. Bailey-Dell, B. Hassel, L.A. Doyle, et al, Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene[J]. Biochim. Biopbys Acta ,2001, 1520:234-241.
  • 6Rocchi E, Khodjakov A, Volk EL, et al. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane[J]. Biochem Biophys Res Commun, 2000, 271 (1): 42- 46.
  • 7C. Ozvegy, T. Litman, G. Szakacs, et al. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells[J]. Biochem. Biophys. Res, Commun, 2001, 285(1):111-117.
  • 8Abbott BL. ABCG2 (BCRP) : a cytoprotectant in normal and malignant stem cells [J]. J Clin Adv Hematol Oncol, 2006,4:63-72.
  • 9Enokizono J , Kusuhara H. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect [J]. J Drug Metab Dispos, 2007, 35:209-214.
  • 10Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrpl/ ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype [J]. Nat Med ,2001 , 7 (9) : 1028-1034.

共引文献46

同被引文献55

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部